These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28171876)

  • 21. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
    J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
    Rumayor Piña A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
    Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk human papillomavirus in nasopharyngeal carcinoma.
    Singhi AD; Califano J; Westra WH
    Head Neck; 2012 Feb; 34(2):213-8. PubMed ID: 21484924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis.
    Simon J; Brenner N; Reich S; Langseth H; Hansen BT; Ursin G; Ferreiro-Iglesias A; Brennan P; Kreimer AR; Johansson M; Pring M; Nygard M; Waterboer T
    Cancer Epidemiol; 2022 Apr; 77():102117. PubMed ID: 35121404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
    Sengar M; Chorghe S; Jadhav K; Singh S; Laskar SG; Pai P; Aggarwal JP; D'Cruz A; Chaturvedi P; Deshpande M; Chaukar D; Budrukkar A; Gupta T; Murthy V; Kane S; Thakur M; Rangarajan V; Kannan S; Shet T; Kode J
    Head Neck; 2016 Apr; 38 Suppl 1():E1666-73. PubMed ID: 26667883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction.
    Punwaney R; Brandwein MS; Zhang DY; Urken ML; Cheng R; Park CS; Li HB; Li X
    Head Neck; 1999 Jan; 21(1):21-9. PubMed ID: 9890347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases.
    Jannapureddy S; Cohen C; Lau S; Beitler JJ; Siddiqui MT
    Diagn Cytopathol; 2010 Nov; 38(11):795-800. PubMed ID: 20014308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of hepatitis B viral infection in Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Xu T; Huang Z; Deng Y; Wang S; Su B; Wei W; Wang D; Jiang J; Li A; Zhang G; Yang H; Claret FX; Hu W
    J Clin Virol; 2015 Mar; 64():64-71. PubMed ID: 25728081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.
    Bar-Sela G; Kuten A; Minkov I; Gov-Ari E; Ben-Izhak O
    J Clin Pathol; 2004 Mar; 57(3):290-3. PubMed ID: 14990602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma.
    Rassekh CH; Rady PL; Arany I; Tyring SK; Knudsen S; Calhoun KH; Seikaly H; Bailey BJ
    Laryngoscope; 1998 Mar; 108(3):362-7. PubMed ID: 9504608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma.
    Gao W; Li ZH; Chen S; Chan JY; Yin M; Zhang MJ; Wong TS
    Oncotarget; 2017 Mar; 8(12):20297-20308. PubMed ID: 28423621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.
    Xu T; Shen C; Wei Y; Hu C; Wang Y; Xiang J; Sun GH; Su F; Wang Q; Lu X
    Cancer Med; 2020 Sep; 9(18):6556-6564. PubMed ID: 32717137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
    Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
    Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
    Wu SS; Chen B; Fleming CW; Shah AA; Griffith CC; Domb C; Reddy CA; Campbell SR; Woody NM; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman L; Geiger JL; Koyfman SA; Ku JA
    Head Neck; 2022 Apr; 44(4):851-861. PubMed ID: 35040516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].
    Han J; He D; Feng ZY; Ding YG; Shao CK
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):798-803. PubMed ID: 21215093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
    Liu MZ; Fang SG; Huang W; Wang HY; Tian YM; Huang RD; Sun Z; Zhao C; Lu TX; Huang Y; Han F
    Cancer Med; 2019 Aug; 8(10):4633-4643. PubMed ID: 31268626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.
    Maxwell JH; Kumar B; Feng FY; McHugh JB; Cordell KG; Eisbruch A; Worden FP; Wolf GT; Prince ME; Moyer JS; Teknos TN; Chepeha DB; Stoerker J; Walline H; Carey TE; Bradford CR
    Head Neck; 2010 May; 32(5):562-7. PubMed ID: 19757421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
    Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
    J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.